Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Breast Cancer Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01263145
What this trial is testing

MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer

Who this might be right for
Adult Solid NeoplasmRecurrent Breast CarcinomaStage IV Breast Cancer
National Cancer Institute (NCI) 34
Early research (Phase 1)Ended earlyNCT04541225
What this trial is testing

Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors

Who this might be right for
GliomaGlioma, MalignantGlioma, Mixed+21 more
Nuvation Bio Inc. 74
Testing effectiveness (Phase 2)Study completedNCT05054374
What this trial is testing

Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer

Who this might be right for
Breast CancerBreast Cancer Stage IVHER2-negative Breast Cancer+4 more
Memorial Sloan Kettering Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00570921
What this trial is testing

Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure

Who this might be right for
Breast Cancer
Mara Chambers 33
Testing effectiveness (Phase 2)Study completedNCT00704158
What this trial is testing

Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
CuraGen Corporation 42
Testing effectiveness (Phase 2)Study completedNCT00005817
What this trial is testing

Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer

Who this might be right for
Male Breast CancerRecurrent Breast CancerStage IIIB Breast Cancer+1 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT04132960
What this trial is testing

Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis

Who this might be right for
Breast Tumors
UNICANCER 186
Testing effectiveness (Phase 2)Study completedNCT05963997
What this trial is testing

Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer

Who this might be right for
Metastatic Breast CancerLocally Advanced Breast CancerBreast Cancer
Carrick Therapeutics Limited 49
Testing effectiveness (Phase 2)Study completedNCT00305825
What this trial is testing

Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery

Who this might be right for
Breast Cancer
University of California, San Francisco 43
Not applicableUnknownNCT02109913
What this trial is testing

Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane

Who this might be right for
Hormone Receptor Positive Malignant Neoplasm of BreastMetastatic Breast Cancer
Amsterdam UMC, location VUmc 175
Early research (Phase 1)Study completedNCT01097460
What this trial is testing

MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer

Who this might be right for
Breast Neoplasms
Merrimack Pharmaceuticals 16
Testing effectiveness (Phase 2)UnknownNCT00006433
What this trial is testing

Phase I/II Trial of Doxil and Hyperthermia for Breast Cancer Patients With Chest Wall Recurrence or Stage IV Disease With Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
National Center for Research Resources (NCRR)
Early research (Phase 1)Study completedNCT00513058
What this trial is testing

Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
UNICANCER 33
Testing effectiveness (Phase 2)Study completedNCT04408118
What this trial is testing

First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBC

Who this might be right for
Metastatic Breast CancerAdvanced Breast CancerTriple Negative Breast Cancer
MedSIR 100
Large-scale testing (Phase 3)Ended earlyNCT00508274
What this trial is testing

Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China

Who this might be right for
Neoplasms, Breast
Novartis Pharmaceuticals 52
Not applicableStudy completedNCT05770713
What this trial is testing

A Real-life Study to Learn About the Use and Effects of the CDK4/6 Inhibitors in Canadian Patients With Breast Cancer.

Who this might be right for
Breast Cancer
Pfizer 48
Early research (Phase 1)Looking for participantsNCT06999798
What this trial is testing

An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+1 more
Mayo Clinic 20
Testing effectiveness (Phase 2)Study completedNCT00003352
What this trial is testing

Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 89
Large-scale testing (Phase 3)Study completedNCT00863655
What this trial is testing

Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 724
Not applicableStudy completedNCT01876238
What this trial is testing

Feasibility of a Team Approach for Discussing Prognosis and Treatment Goals in Breast Cancer

Who this might be right for
Advanced Breast CancerStage 4 Breast CancerRecurrent Breast Cancer
Case Comprehensive Cancer Center 29
Next Page